<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30191956</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>07</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1097-0215</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                        <Day>07</Day>                    </PubDate>                </JournalIssue>                <Title>International journal of cancer</Title>                <ISOAbbreviation>Int. J. Cancer</ISOAbbreviation>            </Journal>            <ArticleTitle>Circulating insulin-like growth factor I in relation to melanoma risk in the European Prospective Investigation into Cancer and Nutrition.</ArticleTitle>            <ELocationID EIdType="doi" ValidYN="Y">10.1002/ijc.31854</ELocationID>            <Abstract>                <AbstractText>Insulin-like growth factor (IGF-I) regulates cell proliferation and apoptosis, and is thought to play a role in tumour development. Previous prospective studies have shown that higher circulating concentrations of IGF-I are associated with a higher risk of cancers at specific sites, including breast and prostate. No prospective study has examined the association between circulating IGF-I concentrations and melanoma risk. A nested case-control study of 1221 melanoma cases and 1221 controls was performed in the European Prospective Investigation into Cancer and Nutrition cohort, a prospective cohort of 520,000 participants recruited from 10 European countries. Conditional logistic regression was used to estimate odds ratios (ORs) for incident melanoma in relation to circulating IGF-I concentrations, measured by immunoassay. Analyses were conditioned on the matching factors and further adjusted for age at blood collection, education, height, BMI, smoking status, alcohol intake, marital status, physical activity, and in women only, use of menopausal hormone therapy. There was no significant association between circulating IGF-I concentration and melanoma risk (OR for highest vs lowest fifth=0.93 (95% confidence interval (CI): 0.71 to 1.22)). There was no significant heterogeneity in the association between IGF-I concentrations and melanoma risk when subdivided by sex, age at blood collection, BMI, height, age at diagnosis, time between blood collection and diagnosis, or by anatomical site or histological subtype of the tumour (Pheterogeneity≥0.078). We found no evidence for an association between circulating concentrations of IGF-I measured in adulthood and the risk of melanoma. This article is protected by copyright. All rights reserved.</AbstractText>                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Bradbury</LastName>                    <ForeName>Kathryn E</ForeName>                    <Initials>KE</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0003-3345-7333</Identifier>                    <AffiliationInfo>                        <Affiliation>Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>National Institute for Health Innovation, School of Population Health, The University of Auckland, Auckland, New Zealand.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Appleby</LastName>                    <ForeName>Paul N</ForeName>                    <Initials>PN</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tipper</LastName>                    <ForeName>Sarah J</ForeName>                    <Initials>SJ</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Travis</LastName>                    <ForeName>Ruth C</ForeName>                    <Initials>RC</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Allen</LastName>                    <ForeName>Naomi E</ForeName>                    <Initials>NE</Initials>                    <AffiliationInfo>                        <Affiliation>Clinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kvaskoff</LastName>                    <ForeName>Marina</ForeName>                    <Initials>M</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-4557-3772</Identifier>                    <AffiliationInfo>                        <Affiliation>CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Gustave Roussy, Villejuif, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Overvad</LastName>                    <ForeName>Kim</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Aarhus University, Department of Public Health, Section for Epidemiology, Aarhus, Denmark.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tjønneland</LastName>                    <ForeName>Anne</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Danish Cancer Society Research Center, Copenhagen, Denmark.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Halkjaer</LastName>                    <ForeName>Jytte</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Danish Cancer Society Research Center, Copenhagen, Denmark.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Cevenka</LastName>                    <ForeName>Iris</ForeName>                    <Initials>I</Initials>                    <AffiliationInfo>                        <Affiliation>CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Gustave Roussy, Villejuif, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mahamat-Saleh</LastName>                    <ForeName>Yahya</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Gustave Roussy, Villejuif, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bonnet</LastName>                    <ForeName>Fabrice</ForeName>                    <Initials>F</Initials>                    <AffiliationInfo>                        <Affiliation>CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Gustave Roussy, Villejuif, France.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>CHU Rennes, Université de Rennes 1, Rennes, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kaaks</LastName>                    <ForeName>Rudolf</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Turzanski Fortner</LastName>                    <ForeName>Renée</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Boeing</LastName>                    <ForeName>Heiner</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE), Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Trichopoulou</LastName>                    <ForeName>Antonia</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Hellenic Health Foundation, Athens, Greece.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>La Vecchia</LastName>                    <ForeName>Carlo</ForeName>                    <Initials>C</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0003-1441-897X</Identifier>                    <AffiliationInfo>                        <Affiliation>Hellenic Health Foundation, Athens, Greece.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Clinical Sciences and Community Health, Università degli Studi di Milano.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Stratigos</LastName>                    <ForeName>Alexander J</ForeName>                    <Initials>AJ</Initials>                    <AffiliationInfo>                        <Affiliation>Hellenic Health Foundation, Athens, Greece.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>1st Department of Dermatology - Venereology, National and Kapodistrian University of Athens School of Medicine, Andreas Sygros Hospital, Athens, Greece.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Palli</LastName>                    <ForeName>Domenico</ForeName>                    <Initials>D</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-5558-2437</Identifier>                    <AffiliationInfo>                        <Affiliation>Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network, ISPRO, Florence, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Grioni</LastName>                    <ForeName>Sara</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Matullo</LastName>                    <ForeName>Giuseppe</ForeName>                    <Initials>G</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0003-0674-7757</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Medical Sciences, University of Torino, Italy.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Italian Institute for Genomic Medicine (IIGM/fka HuGeF), Torino, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Panico</LastName>                    <ForeName>Salvatore</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Dipartmento di Medicina Clinica E Chirurgia, Federico II University, Naples, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tumino</LastName>                    <ForeName>Rosario</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Registry and Histopathology Department, &quot;Civic - M.P. Arezzo&quot; Hospital, ASP, Ragusa, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Peeters</LastName>                    <ForeName>Petra H</ForeName>                    <Initials>PH</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bueno-de-Mesquita</LastName>                    <ForeName>Bas</ForeName>                    <Initials>B</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, St Mary's Campus, Norfolk Place, London, W2 1PG, United Kingdom.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Pantai Valley, 50603, Kuala Lumpur, Malaysia.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ghiasvand</LastName>                    <ForeName>Reza</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Norway.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Veierød</LastName>                    <ForeName>Marit B</ForeName>                    <Initials>MB</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-2083-2758</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Weiderpass</LastName>                    <ForeName>Elisabete</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Genetic Epidemiology Group, Folkhälsan Research Center and Faculty of Medicine, University of Helsinki, Finland.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bonet</LastName>                    <ForeName>Catalina</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Molina</LastName>                    <ForeName>Elena</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Escuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria ibs, GRANADA, Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Huerta</LastName>                    <ForeName>José María</ForeName>                    <Initials>JM</Initials>                    <AffiliationInfo>                        <Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Larrañaga</LastName>                    <ForeName>Nerea</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Public Health Division of Gipuzkoa-BIODONOSTIA, Basque Regional Health Department.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Barricarte</LastName>                    <ForeName>Aurelio</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Navarra Public Health Institute, Pamplona, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Merino</LastName>                    <ForeName>Susana</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Public Health Directorate, Asturias, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Isaksson</LastName>                    <ForeName>Karolin</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Breast and Melanoma Unit, Lund University, Skåne University Hospital, Department of Clinical Sciences, Surgery, Lund, Sweden.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Stocks</LastName>                    <ForeName>Tanja</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Clinical Sciences Malmö, Lund University, Sweden.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ljuslinder</LastName>                    <ForeName>Ingrid</ForeName>                    <Initials>I</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-5046-1820</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Sciences, Oncology, Norrlands University Hospital, Umeå, Sweden.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hemmingsson</LastName>                    <ForeName>Oskar</ForeName>                    <Initials>O</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgical and perioperative Sciences/Surgery, Umeå University, Umeå, Sweden.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wareham</LastName>                    <ForeName>Nick</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>MRC Epidemiology Unit, University of Cambridge, Cambridge, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Khaw</LastName>                    <ForeName>Kay-Tee</ForeName>                    <Initials>KT</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Gunter</LastName>                    <ForeName>Marc J</ForeName>                    <Initials>MJ</Initials>                    <AffiliationInfo>                        <Affiliation>Section of Nutrition and Metabolism, International Agency for Research on Cancer, World Health Organization, Lyon, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Rinaldi</LastName>                    <ForeName>Sabina</ForeName>                    <Initials>S</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-6846-1204</Identifier>                    <AffiliationInfo>                        <Affiliation>Section of Nutrition and Metabolism, International Agency for Research on Cancer, World Health Organization, Lyon, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tsilidis</LastName>                    <ForeName>Konstantinos K</ForeName>                    <Initials>KK</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Epidemiology and Biostatistics, Faculty of Medicine, School of Public Health, Imperial College London, UK.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Aune</LastName>                    <ForeName>Dagfinn</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Epidemiology and Biostatistics, Faculty of Medicine, School of Public Health, Imperial College London, UK.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Nutrition, Bjørknes University College, Oslo, Norway.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Riboli</LastName>                    <ForeName>Elio</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Epidemiology and Biostatistics, Faculty of Medicine, School of Public Health, Imperial College London, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Key</LastName>                    <ForeName>Timothy J</ForeName>                    <Initials>TJ</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>07</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Int J Cancer</MedlineTA>            <NlmUniqueID>0042124</NlmUniqueID>            <ISSNLinking>0020-7136</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">EPIC</Keyword>            <Keyword MajorTopicYN="N">IGF-I</Keyword>            <Keyword MajorTopicYN="N">biomarker</Keyword>            <Keyword MajorTopicYN="N">height</Keyword>            <Keyword MajorTopicYN="N">insulin-like growth factor I</Keyword>            <Keyword MajorTopicYN="N">melanoma</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>06</Month>                <Day>07</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>07</Month>                <Day>23</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>25</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>8</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>8</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>8</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30191956</ArticleId>            <ArticleId IdType="doi">10.1002/ijc.31854</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>